HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Interpretation of The "14th Five-Year Plan" For the Development of China Pharmaceutical Industry

Would the Cheap Versions of Oral COVID-19 Antiviral Bring New Opportunities for Chinese Companies?

China Healthcare Weekly (Feb.11)- “14th Five-Year Plan” For Medical Beauty, Wuxi Biologics, Innovent

China Healthcare Weekly (Jan.14) - Impact on Dental Implant VBP, Prediction on 7th National VBP 2022

China Healthcare Weekly (Jan.28) - 7th National VBP, Taking History as a Mirror, Confidence Rebuilt

China Healthcare Weekly (Jan.21)-Growth Hormone VBP,Biotech Survival,Internationalization Conditions

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Thematic (Sector/Industry)

Hong kong Pharmaceuticals, biotechnology and life sciences / Thematic (Sector/Industry)

<ul>
<li>The "14th Five-year Plan" for the development of pharmaceutical industry was released. China's attention to the internationalization development of the pharmaceutical industry has risen to a new height.</li>
<li>There are still many real clinical needs that need to be addressed through innovation. So, this requires a change in thinking and a broadening of cognitive boundaries.</li>
<li>For some biotech, it is very difficult to have successful commercialization without differentiating products. Companies have to know how to “define” a good product,which is the right way to innovate.</li>
</ul>


The "14th Five-year Plan" for the development of pharmaceutical industry was released. China's attention to the internationalization development of the pharmaceutical industry has risen to a new height.
There are still many real clinical needs that need to be addressed through innovation. So, this requires a change in thinking and a broadening of cognitive boundaries.
For some biotech, it is very difficult to have successful commercialization without differentiating products. Companies have to know how to “define” a good product,which is the right way to innovate.


China Healthcare Weekly (Feb.4)- "14th Five-Year Plan" Of Pharmaceuticals, the Right Way to Innovate